FNY Partners Fund’s Kite Pharma, Inc. KITE Stock Holding History

FNY Partners Fund’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-2,827	Closed	-$19M	–	713
2017 Q3	$19M	Buy	+2,827	New	+$394K	3.24%	9

FNY Partners Fund's KITE Position: Q4 2017 in Review

FNY Partners Fund sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 379,510 shares — an estimated $68.2M sold.

FNY Partners Fund first reported a position in KITE in Q3 2017 and held it in 1 quarter. The position peaked at $68.2M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

FNY Partners Fund reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
FNY Partners Fund sold 379,510 Kite Pharma, Inc. shares in Q4 2017, an estimated $68.2M.
FNY Partners Fund first reported a position in Kite Pharma, Inc. in Q3 2017 and held it in 1 quarter.
FNY Partners Fund's Kite Pharma, Inc. position peaked at $68.2M in Q3 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on FNY Partners Fund's 13F filing for Q4 2017, filed 24 Jan 2018.